Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1376)
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
10,310
Price
$69.20
Total Value
$713.45K
Shares Held After
635,686
% of Holdings
1.6%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
9,690
Price
$68.36
Total Value
$662.44K
Shares Held After
645,996
% of Holdings
1.5%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
253
Price
$27.82
Total Value
$7.04K
Shares Held After
76,140
% of Holdings
0.3%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
3,079
Price
$27.37
Total Value
$84.26K
Shares Held After
76,393
% of Holdings
3.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
10,726
Price
$25.91
Total Value
$277.92K
Shares Held After
79,472
% of Holdings
11.9%
Zai Lab Ltd (ZLAB)
Amado Rafael — President, Head of Global Oncology Research and Development
Shares
2,957
Price
$18.63
Total Value
$55.08K
Shares Held After
44,757
% of Holdings
6.2%
Zai Lab Ltd (ZLAB)
Edmondson Frazor Titus III — Chief Legal Officer
Shares
1,281
Price
$18.63
Total Value
$23.86K
Shares Held After
6,494
% of Holdings
16.5%
Zai Lab Ltd (ZLAB)
Chen Yajing — Chief Financial Officer
Shares
1,703
Price
$18.63
Total Value
$31.72K
Shares Held After
19,999
% of Holdings
7.8%
Zai Lab Ltd (ZLAB)
Smiley Joshua L — President and Chief Operating Officer
Shares
1,966
Price
$18.63
Total Value
$36.62K
Shares Held After
91,026
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$542.03
Total Value
$43.36K
Shares Held After
130
% of Holdings
38.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$541.21
Total Value
$259.78K
Shares Held After
210
% of Holdings
69.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
865
Price
$540.27
Total Value
$467.33K
Shares Held After
690
% of Holdings
55.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,546
Price
$539.26
Total Value
$833.70K
Shares Held After
1,555
% of Holdings
49.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,019
Price
$538.31
Total Value
$1.09M
Shares Held After
3,101
% of Holdings
39.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,030
Price
$537.29
Total Value
$1.09M
Shares Held After
5,120
% of Holdings
28.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,536
Price
$536.32
Total Value
$823.79K
Shares Held After
7,150
% of Holdings
17.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
944
Price
$535.43
Total Value
$505.44K
Shares Held After
8,686
% of Holdings
9.8%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
1,703
Price
$99.71
Total Value
$169.81K
Shares Held After
65,604
% of Holdings
2.5%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
2,597
Price
$98.83
Total Value
$256.66K
Shares Held After
67,307
% of Holdings
3.7%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
804
Price
$97.89
Total Value
$78.70K
Shares Held After
69,904
% of Holdings
1.1%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
10,000
Price
$4.29
Total Value
$42.90K
Shares Held After
1,086,467
% of Holdings
0.9%
MBX Biosciences, Inc. (MBX)
Hawryluk P. Kent — Director
Shares
18,500
Price
$28.41
Total Value
$525.66K
Shares Held After
486,777
% of Holdings
3.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$12.96
Total Value
$247.02K
Shares Held After
507,934
% of Holdings
3.6%
Xenon Pharmaceuticals Inc. (XENE)
KENNEY CHRISTOPHER JOHN — Chief Medical Officer
Shares
1,410
Price
$55.23
Total Value
$77.87K
Shares Held After
7,069
% of Holdings
16.6%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
7,308
Price
$55.23
Total Value
$403.58K
Shares Held After
19,923
% of Holdings
26.8%
Xenon Pharmaceuticals Inc. (XENE)
DiFabio Andrea — Chief Legal Officer
Shares
1,342
Price
$55.23
Total Value
$74.11K
Shares Held After
7,301
% of Holdings
15.5%
Centessa Pharmaceuticals plc (CNTA)
Weinhoff Gregory M — Chief Business Officer
Shares
11,943
Price
$27.16
Total Value
$324.34K
Shares Held After
65,925
% of Holdings
15.3%
Centessa Pharmaceuticals plc (CNTA)
Weinhoff Gregory M — Chief Business Officer
Shares
61,253
Price
$26.17
Total Value
$1.60M
Shares Held After
77,868
% of Holdings
44.0%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
12,068
Price
$27.13
Total Value
$327.44K
Shares Held After
62,085
% of Holdings
16.3%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
107,961
Price
$26.15
Total Value
$2.82M
Shares Held After
74,153
% of Holdings
59.3%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
370,000
Price
$5.00
Total Value
$1.85M
Shares Held After
0
% of Holdings
100.0%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
6,187
Price
$24.99
Total Value
$154.58K
Shares Held After
657,299
% of Holdings
0.9%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
6,187
Price
$24.99
Total Value
$154.58K
Shares Held After
657,301
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
300
Price
$70.15
Total Value
$21.05K
Shares Held After
4,458,447
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,815
Price
$69.29
Total Value
$402.93K
Shares Held After
4,458,747
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
13,885
Price
$68.47
Total Value
$950.69K
Shares Held After
4,464,562
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
300
Price
$70.15
Total Value
$21.05K
Shares Held After
655,686
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,363
Price
$69.32
Total Value
$371.75K
Shares Held After
655,986
% of Holdings
0.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
14,337
Price
$68.48
Total Value
$981.81K
Shares Held After
661,349
% of Holdings
2.1%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Title: Chief Technology and Manufacturing Officer
Shares
10,076
Price
$2.55
Total Value
$25.68K
Shares Held After
515,427
% of Holdings
1.9%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
7,043
Price
$2.55
Total Value
$17.95K
Shares Held After
507,261
% of Holdings
1.4%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$27.37
Total Value
$173.75K
Shares Held After
82,489
% of Holdings
7.1%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
306
Price
$99.12
Total Value
$30.33K
Shares Held After
70,708
% of Holdings
0.4%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
5,505
Price
$98.44
Total Value
$541.91K
Shares Held After
71,014
% of Holdings
7.2%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
24,189
Price
$97.79
Total Value
$2.37M
Shares Held After
76,519
% of Holdings
24.0%
Absci Corp (ABSI)
Busch Andreas — Chief Innovation Officer
Shares
100,000
Price
$2.29
Total Value
$229.00K
Shares Held After
421,446
% of Holdings
23.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
164
Price
$544.58
Total Value
$89.31K
Shares Held After
130
% of Holdings
55.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
356
Price
$543.22
Total Value
$193.39K
Shares Held After
294
% of Holdings
54.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$542.33
Total Value
$325.40K
Shares Held After
650
% of Holdings
48.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$541.31
Total Value
$216.52K
Shares Held After
1,250
% of Holdings
24.2%
Showing 351–400 of 1376 transactions (page 8 of 28)